| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90c3702d69494d24f691303fe630cc94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09d195fadc42b53435890ef8d96e7bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f677855b41682531902de49afbd5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf85c995ccaf0d27cd9f8bac14b7ce20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b6bed385b12386c8396402a1caf0b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dcb4f12ea386f7f83515b8b19f39d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4aa9994b991d765ba6f52167f7d8d31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af9a111117d20ecf525c76e26daa40b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2320c55301e5298f4da8ef365aeda792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87733d521bb0bd5932c206a3fcf6a275 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
| filingDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac8f9c3c1f1332093b37da503e9f629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc83917e0cf0938b096d66009ab8bac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b923eb9d80af475076671de57c900245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f49c1a12d4a8a5ba878450041b002b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cfc3e4618bb5c9caba1df10fa931a96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021b48a0a67b1eb64575f2e084af9b3e |
| publicationDate |
2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013045542-A1 |
| titleOfInvention |
New formulations for diagnosis of alzheimer's disease |
| abstract |
A method of using at least one quantitative ratio of two different amyloid beta-peptides in a sample of a body fluid from a patient for determining the patient's probability of contracting Alzheimer's disease (AD) or for determining the patient's suffering from a precursor of Alzheimer's disease includes obtaining the sample of the body fluid from the patient. The at least one quantitative ratio is calculated from the two different amyloid beta-peptides from the sample. The patient's probability of contracting Alzheimer's disease (AD) or the patient's suffering from a precursor of Alzheimer's disease is calculated using the at least one quantitative ratio. The two different amyloid beta-peptides are selected from (a) Aβ(1-42), (b) Aβ(2-40) and (c) Aβ(2-42). The at least one quantitative ratio is selected from (a) Aβ(1-42)/(b) Aβ(2-40), (a) Aβ(1-42)/(c) Aβ(2-42), (b) Aβ(2-40)/(a) Aβ(1-42) and (c) Aβ(2-42)/(a) Aβ(1-42). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021083977-A1 |
| priorityDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |